Wockhardt Limited Share Price & Analysis
₹2088.70+7.08%Updated 4 Sept 2026, 03:30 pm IST
LTP
₹2088.70+7.08%Open
₹1980.00High
₹2107.00Low
₹1976.20Close
₹2088.7052W High
₹2422.3052W Low
₹1086.70Volume
3558KLot Size
1Sector
HealthcareMarket Cap
₹34K CrFace Value
₹5Large CapNIFTY 500SMALLCAP 100Nifty Smallcap 250
Price Chart
Candle
Range
Fundamentals
P/E
85.10Sector P/E
54.70P/B
6.98EPS
₹13.13ROE
6.11%ROCE
7.55%D/E Ratio
0.42Div Yield
0.00%Book Value
₹304.00Strengths
- Low debt relative to equity (D/E 0.4x)
Concerns
- Premium to sector peers (P/E 85.1x vs industry 54.7x)
Peer Comparison
| Company | CMP | Mkt Cap | P/E | P/B | ROE % | ROCE % | D/E |
|---|---|---|---|---|---|---|---|
| SUNPHARMA Sun Pharmaceutical Industries Limited | ₹1,899 | ₹4.6L Cr | 36.1 | 5.46 | 16 | 20.5 | 0.07 |
| DIVISLAB Divi's Laboratories Limited | ₹9,100 | ₹2.4L Cr | 81.1 | 14.42 | 16.5 | 22 | 0.01 |
| TORNTPHARM Torrent Pharmaceuticals Limited | ₹4,857 | ₹1.8L Cr | 82.8 | 19.58 | 27.4 | 15.2 | 0.33 |
| APOLLOHOSP Apollo Hospitals Enterprise Limited | ₹8,650 | ₹1.2L Cr | 59.1 | 13.13 | 21.2 | 17.4 | 0.88 |
| CIPLA Cipla Limited | ₹1,385 | ₹1.1L Cr | 31.3 | 3.25 | 11.6 | 15.5 | 0.01 |
| ZYDUSLIFE Zydus Lifesciences Limited | ₹1,120 | ₹1.1L Cr | 23 | 4.16 | 21.2 | 21.1 | 0.38 |
| LAURUSLABS Laurus Labs Limited | ₹1,840 | ₹99K Cr | 90.9 | 18.74 | 18.3 | 17.8 | 0.46 |
Showing 7 peers in the same sector · Sorted by market cap
Shareholding Pattern
WOCKPHARMA · as of Mar 2026
Promoters49.09%
FII6.82%0.28pp
DII10.58%0.76pp
Public33.50%1.04pp
Govt0.02%
| Category | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoters | 54.93% | 51.60% | 51.99% | 51.99% | 49.09% | 49.09% |
| FII | 4.18% | 5.49% | 5.94% | 6.70% | 6.54% | 6.82% |
| DII | 0.30% | 4.82% | 4.45% | 5.08% | 9.82% | 10.58% |
| Public | 40.59% | 38.06% | 37.62% | 36.21% | 34.54% | 33.50% |
| Govt | — | 0.01% | 0.01% | 0.02% | 0.02% | 0.02% |
Corporate Events
Pursuant to Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that a meeting of the Board of Directors of the Company will be held on Monday, 10th August, 2026, inter-alia, to consider and
Results9 Aug 2026
Annual General Meeting
AGM20 Jun 2024
Annual General Meeting
AGM6 Aug 2023
Latest News
All newsWockhardt announces board meeting outcome
*Wockhardt announces board meeting outcome.* The company disclosed the outcome of its recent board meeting as per SEBI listing norms. No major financial figures or strategic decisions were revealed in the update. This is a routine regulatory disclosure. 📊 *STOCKS:* $WOCKPHARMA | 🏢 *SECTOR:* Pharma | #LOWIMPACT #BoardMeeting
NSE Filing10 Aug
Wockhardt announces 27th AGM via newspaper notice
*Wockhardt announces 27th AGM via newspaper notice.* The company published public notices in Lokmat and Business Standard on **July 3, 2026**, for its upcoming AGM. This is part of compliance under SEBI Listing Regulations. No financial or operational updates were disclosed. 📊 *STOCKS:* WOCKPHARMA | 🏢 *SECTOR:* Pharma | #LOWIMPACT #AGM
NSE Filing3 Jul
Wockhardt shares may react to investor meet updates
*Wockhardt shares may react to investor meet updates.* The company shared the transcript of its recent Analyst/Institutional Investor Meet pursuant to SEBI listing regulations. No major financial announcements or strategic shifts were disclosed. **No material triggers** for immediate trading action noted. 📊 *STOCKS:* WOCKPHARMA | 🏢 *SECTOR:* Pharma | #LOWIMPACT #InvestorMeet
NSE Filing11 Jun
Financials
Quarterly Results
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹965 Cr 8.7% | ₹888 Cr 13.6% | ₹782 Cr 6.0% | ₹738 Cr 0.7% | ₹743 Cr 3.1% | ₹721 Cr 10.9% | ₹809 Cr 9.5% | ₹739 Cr |
| Op. Profit | ₹225 Cr 27.1% | ₹177 Cr 0.6% | ₹178 Cr 147.2% | ₹72 Cr 12.5% | ₹64 Cr 50.0% | ₹128 Cr 16.4% | ₹110 Cr 20.9% | ₹91 Cr |
| OPM | 23.0% 15.0% | 20.0% 13.0% | 23.0% 130.0% | 10.0% 11.1% | 9.0% 50.0% | 18.0% 28.6% | 14.0% 16.7% | 12.0% |
| Net Profit | ₹164 Cr 168.9% | ₹61 Cr 25.6% | ₹82 Cr 175.9% | ₹-108 Cr 140.0% | ₹-45 Cr 325.0% | ₹20 Cr 225.0% | ₹-16 Cr 0.0% | ₹-16 Cr |
| EPS (₹) | 10.22 181.5% | 3.63 24.4% | 4.8 186.6% | -5.54 259.7% | -1.54 279.1% | 0.86 160.1% | -1.43 57.1% | -0.91 |
Values in ₹ Cr · Source: Screener.in
Annual Profit & Loss
| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ₹3.4K Cr 12.0% | ₹3.0K Cr 7.6% | ₹2.8K Cr 5.5% | ₹2.7K Cr 17.9% | ₹3.2K Cr 19.3% | ₹2.7K Cr 4.8% | ₹2.8K Cr 20.2% | ₹3.6K Cr 9.4% | ₹3.9K Cr 1.9% | ₹4.0K Cr |
| Expenses | ₹2.7K Cr 3.9% | ₹2.6K Cr 3.3% | ₹2.7K Cr 6.2% | ₹2.5K Cr 13.1% | ₹2.9K Cr 5.8% | ₹2.8K Cr 1.7% | ₹2.7K Cr 24.4% | ₹3.6K Cr 8.4% | ₹3.9K Cr 1.7% | ₹4.0K Cr |
| Op. Profit | ₹652 Cr 65.9% | ₹393 Cr 331.9% | ₹91 Cr 10.8% | ₹102 Cr 65.8% | ₹298 Cr 573.0% | ₹-63 Cr 152.9% | ₹119 Cr 413.2% | ₹-38 Cr 2000.0% | ₹2 Cr 84.6% | ₹13 Cr |
| OPM | 19.0% 46.2% | 13.0% 306.3% | 3.2% 17.9% | 3.9% 56.7% | 9.0% 491.3% | -2.3% 154.8% | 4.2% 481.8% | -1.1% 1200.0% | 0.1% 66.7% | 0.3% |
| Other Income | ₹26 Cr 58.1% | ₹62 Cr 264.7% | ₹17 Cr 109.8% | ₹-173 Cr 6.1% | ₹-163 Cr 116.7% | ₹975 Cr 633.1% | ₹133 Cr 14.7% | ₹116 Cr 148.7% | ₹-238 Cr 308.8% | ₹114 Cr |
| Interest | ₹213 Cr 16.1% | ₹254 Cr 16.7% | ₹305 Cr 1.0% | ₹302 Cr 1.0% | ₹299 Cr 20.1% | ₹249 Cr 9.8% | ₹276 Cr 4.2% | ₹265 Cr 3.9% | ₹255 Cr 13.3% | ₹225 Cr |
| Depreciation | ₹227 Cr 4.6% | ₹217 Cr 2.7% | ₹223 Cr 11.2% | ₹251 Cr 1.6% | ₹247 Cr 0.4% | ₹246 Cr 9.8% | ₹224 Cr 36.6% | ₹164 Cr 9.3% | ₹150 Cr 0.7% | ₹149 Cr |
| PBT | ₹238 Cr 1587.5% | ₹-16 Cr 96.2% | ₹-420 Cr 32.7% | ₹-624 Cr 51.8% | ₹-411 Cr 198.6% | ₹417 Cr 268.8% | ₹-247 Cr 29.6% | ₹-351 Cr 45.2% | ₹-641 Cr 159.5% | ₹-247 Cr |
| Tax % | 16.0% 93.8% | 256.0% 2033.3% | 12.0% | 0.0% 100.0% | -32.0% 50.8% | -65.0% 20.7% | -82.0% 115.8% | -38.0% 1050.0% | 4.0% 144.4% | -9.0% |
| Net Profit | ₹199 Cr 449.1% | ₹-57 Cr 87.9% | ₹-472 Cr 24.0% | ₹-621 Cr 122.6% | ₹-279 Cr 140.6% | ₹688 Cr 1700.0% | ₹-43 Cr 80.2% | ₹-217 Cr 67.5% | ₹-667 Cr 195.1% | ₹-226 Cr |
| EPS (₹) | 13.11 553.6% | -2.89 90.4% | -30.18 22.2% | -38.8 129.0% | -16.94 135.6% | 47.64 1090.4% | -4.81 64.4% | -13.52 68.0% | -42.3 210.6% | -13.62 |
| Div Payout | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% 100.0% | -56.0% |
Values in ₹ Cr · Source: Screener.in
Balance Sheet
| Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
Liabilities | ||||||||||
| Equity Capital | ₹81 Cr 0.0% | ₹81 Cr 5.2% | ₹77 Cr 6.9% | ₹72 Cr 0.0% | ₹72 Cr 30.9% | ₹55 Cr 0.0% | ₹55 Cr 0.0% | ₹55 Cr 0.0% | ₹55 Cr 0.0% | ₹55 Cr |
| Reserves | ₹4.9K Cr 13.7% | ₹4.3K Cr 30.2% | ₹3.3K Cr 0.0% | ₹3.3K Cr 13.1% | ₹3.8K Cr 13.7% | ₹3.3K Cr 26.9% | ₹2.6K Cr 0.1% | ₹2.6K Cr 6.4% | ₹2.8K Cr 14.8% | ₹3.3K Cr |
| Borrowings | ₹2.2K Cr 10.5% | ₹2.0K Cr 14.2% | ₹2.4K Cr 7.9% | ₹2.2K Cr 0.6% | ₹2.2K Cr 17.8% | ₹2.7K Cr 25.3% | ₹3.6K Cr 6.1% | ₹3.4K Cr 10.0% | ₹3.7K Cr 9.9% | ₹4.2K Cr |
| Other Liabilities | ₹1.4K Cr 18.6% | ₹1.7K Cr 9.1% | ₹1.9K Cr 10.1% | ₹2.1K Cr 2.5% | ₹2.2K Cr 27.8% | ₹1.7K Cr 10.5% | ₹1.9K Cr 7.4% | ₹1.8K Cr 15.4% | ₹1.5K Cr 2.8% | ₹1.5K Cr |
| Total Liabilities | ₹8.6K Cr 5.9% | ₹8.1K Cr 6.4% | ₹7.6K Cr 0.5% | ₹7.7K Cr 6.9% | ₹8.2K Cr 6.1% | ₹7.7K Cr 4.9% | ₹8.1K Cr 4.3% | ₹7.8K Cr 3.9% | ₹8.1K Cr 9.5% | ₹9.0K Cr |
Assets | ||||||||||
| Fixed Assets | ₹2.8K Cr 2.0% | ₹2.7K Cr 5.0% | ₹2.9K Cr 5.3% | ₹3.0K Cr 12.1% | ₹3.5K Cr 3.6% | ₹3.3K Cr 4.5% | ₹3.5K Cr 14.5% | ₹3.1K Cr 5.9% | ₹2.9K Cr 4.1% | ₹2.8K Cr |
| CWIP | ₹2.4K Cr 17.0% | ₹2.0K Cr 18.1% | ₹1.7K Cr 11.9% | ₹1.5K Cr 14.7% | ₹1.3K Cr 2.7% | ₹1.4K Cr 13.0% | ₹1.6K Cr 9.7% | ₹1.4K Cr 0.8% | ₹1.4K Cr 15.2% | ₹1.2K Cr |
| Investments | ₹412 Cr 2.4% | ₹422 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr 100.0% | ₹214 Cr 62.0% | ₹563 Cr |
| Other Assets | ₹3.0K Cr 3.0% | ₹2.9K Cr 3.4% | ₹3.0K Cr 1.9% | ₹3.1K Cr 10.0% | ₹3.4K Cr 12.8% | ₹3.0K Cr 1.2% | ₹3.1K Cr 7.5% | ₹3.3K Cr 7.9% | ₹3.6K Cr 18.4% | ₹4.4K Cr |
| Total Assets | ₹8.6K Cr 5.9% | ₹8.1K Cr 6.4% | ₹7.6K Cr 0.5% | ₹7.7K Cr 6.9% | ₹8.2K Cr 6.1% | ₹7.7K Cr 4.9% | ₹8.1K Cr 4.3% | ₹7.8K Cr 3.9% | ₹8.1K Cr 9.5% | ₹9.0K Cr |
Values in ₹ Cr · Source: Screener.in
Cash Flow Statement
| Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating CF | ₹390 Cr 1872.7% | ₹-22 Cr 110.0% | ₹219 Cr 43.1% | ₹153 Cr 63.0% | ₹413 Cr 243.9% | ₹-287 Cr 144.2% | ₹649 Cr 254.6% | ₹183 Cr 169.1% | ₹68 Cr 125.3% | ₹-269 Cr |
| Investing CF | ₹-231 Cr 70.4% | ₹-780 Cr 465.2% | ₹-138 Cr 16.9% | ₹-118 Cr 42.2% | ₹-204 Cr 113.9% | ₹1.5K Cr 1100.7% | ₹-147 Cr 258.1% | ₹93 Cr 85.4% | ₹635 Cr 192.8% | ₹-684 Cr |
| Financing CF | ₹-54 Cr 113.2% | ₹409 Cr 22.5% | ₹334 Cr 206.0% | ₹-315 Cr 343.7% | ₹-71 Cr 93.9% | ₹-1.2K Cr 72.2% | ₹-680 Cr 12.4% | ₹-776 Cr 0.9% | ₹-769 Cr 161.3% | ₹1.3K Cr |
| Net Cash Flow | ₹105 Cr 126.7% | ₹-393 Cr 194.7% | ₹415 Cr 248.2% | ₹-280 Cr 302.9% | ₹138 Cr 961.5% | ₹13 Cr 107.3% | ₹-178 Cr 64.4% | ₹-500 Cr 657.6% | ₹-66 Cr 121.9% | ₹301 Cr |
| Free Cash Flow | ₹76 Cr 120.2% | ₹-377 Cr 646.4% | ₹69 Cr 200.0% | ₹23 Cr 88.6% | ₹202 Cr 144.7% | ₹-452 Cr 193.0% | ₹486 Cr 282.7% | ₹127 Cr 153.4% | ₹-238 Cr 64.9% | ₹-678 Cr |
Values in ₹ Cr · Source: Screener.in
Key Ratios History
| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 64d 20.0% | 80d 1.2% | 81d 26.4% | 110d 5.8% | 104d 16.1% | 124d 22.0% | 159d 22.3% | 130d 46.1% | 89d 5.3% | 94d |
| Inventory Days | 286d 22.2% | 234d 16.4% | 201d 6.9% | 216d 2.7% | 222d 13.3% | 256d 22.5% | 209d 14.2% | 183d 5.2% | 174d 28.4% | 243d |
| Days Payable | 182d 4.7% | 191d 20.4% | 240d 15.8% | 285d 7.5% | 265d 18.8% | 223d 18.0% | 272d 45.5% | 187d 53.3% | 122d 4.3% | 117d |
| Cash Conv. Cycle | 168d 36.6% | 123d 200.0% | 41d 0.0% | 41d 31.7% | 60d 61.8% | 157d 61.9% | 97d 23.0% | 126d 10.6% | 141d 35.9% | 220d |
| Working Capital Days | 35d 252.2% | -23d 85.9% | -163d 12.4% | -186d 60.3% | -116d 12.8% | -133d 22.2% | -171d 235.3% | -51d 8.9% | -56d 255.6% | 36d |
| ROCE | 8.0% 100.0% | 4.0% 500.0% | -1.0% | 0.0% 100.0% | 1.0% 133.3% | -3.0% 200.0% | -1.0% 0.0% | -1.0% 0.0% | -1.0% 0.0% | -1.0% |
Source: Screener.in · Lower days = better efficiency
Related Analysis
Frequently Asked Questions
What is Wockhardt Limited share price today?
Wockhardt Limited (WOCKPHARMA) is currently trading at ₹2,088.7 on NSE, up 7.08% as of the last market session. Prices update daily after market close on MarketNetra.
Is Wockhardt Limited available in F&O (Futures & Options)?
Yes, Wockhardt Limited (WOCKPHARMA) is part of the NSE F&O segment with a lot size of 1 shares. Options are available with monthly expiry contracts. You can track the full option chain and OI analysis on MarketNetra.
What is Wockhardt Limited 52-week high and low?
Wockhardt Limited's 52-week high is ₹2,422.3 and the 52-week low is ₹1,086.7. The current price of ₹2,088.7 is 13.8% below the 52W high.
What is Wockhardt Limited P/E ratio?
Wockhardt Limited's current P/E ratio is 85.1. This indicates the market is paying ₹85.1 for every ₹1 of earnings. Compare this to the sector average to assess relative valuation.
How to trade Wockhardt Limited options?
Wockhardt Limited options are traded on NSE with monthly expiry contracts (lot size: 1 shares). To trade WOCKPHARMA options: select your expiry on the option chain page, identify key OI strikes, check the PCR and buildup type on OI analysis, and review FII/DII flows for institutional sentiment before taking a position.